Analysis of hydroxychloroquine prescriptions for COVID-19 in Japan

Takashi Watari1,2, Yasuharu Tokuda3,4, Hiromizu Takahashi5

  • 1General Medicine Center Shimane University Shimane Japan.

Insights

Monthly hydroxychloroquine prescriptions for COVID-19 in Japan were tracked from January 2020 to November 2021. Prescription trends were compared against national COVID-19 case notifications.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hydroxychloroquine was investigated as a potential treatment for coronavirus disease 2019 (COVID-19).
  • Understanding prescription patterns is crucial for assessing treatment uptake during the pandemic.

Purpose of the Study:

  • To analyze the monthly prescription trends of hydroxychloroquine for COVID-19 patients in Japan.
  • To compare hydroxychloroquine prescription data with national COVID-19 case counts.

Main Methods:

  • Utilized the Medical Data Vision database, covering approximately 20% of acute care hospitals in Japan.
  • Collected monthly hydroxychloroquine prescription data from January 2020 to November 2021.
  • Correlated prescription data with monthly national COVID-19 notifications.

Main Results:

  • The study presents monthly hydroxychloroquine prescription data (blue bars) and national COVID-19 notifications (gray line).
  • Visual representation allows for direct comparison of drug prescription trends against disease prevalence.

Conclusions:

  • The data provides insights into the clinical use of hydroxychloroquine for COVID-19 in Japan during a specific period.
  • Further analysis can explore the relationship between prescription patterns and public health guidelines or research findings.

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
309
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
101
Pareto Chart00:52

Pareto Chart

A Pareto chart is a bar graph or a combination of both line and bar graphs. The bar lengths represent the individual values or the frequency, while the lines represent the cumulative total values. In this chart, the longest bars are arranged on the left and the shortest bars on the right, which makes it easier to read and interpret the data. It can also be called a Pareto diagram or Pareto analysis.
The Pareto chart is named after the Italian economist Vilfredo Pareto, who described the Pareto...
6.8K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
916
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.1K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
911